Spots Global Cancer Trial Database for theophylline
Every month we try and update this database with for theophylline cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer | NCT01799161 | Non-Small Cell ... Non-small-cell ... Lung Cancer NSCLC | gp96-Ig Vaccine Theophylline Oxygen Immunologic Eva... | 18 Years - | University of Miami | |
A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate Cancer | NCT01017939 | Prostate Neopla... | Abiraterone ace... Prednisone Dextromethorpha... Theophylline | 18 Years - | Janssen Research & Development, LLC | |
A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate Cancer | NCT01017939 | Prostate Neopla... | Abiraterone ace... Prednisone Dextromethorpha... Theophylline | 18 Years - | Janssen Research & Development, LLC | |
Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia | NCT00003808 | Leukemia | theophylline | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
All-trans Retinoic Acid, and Arsenic +/- Idarubicin | NCT00413166 | Acute Promyeloc... | All-Trans Retin... Arsenic Trioxid... Idarubicin Gemtuzumab Ozog... | - | M.D. Anderson Cancer Center | |
Theophylline in Treating Cancer Patients With Shortness of Breath | NCT00003684 | Pulmonary Compl... Quality of Life Unspecified Adu... | theophylline quality-of-life... | 16 Years - 120 Years | Canadian Cancer Trials Group | |
A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline | NCT02080078 | Non-small Cell ... Advanced Solid ... | Theophylline Erlotinib | 18 Years - | AHS Cancer Control Alberta | |
Theophylline in Treating Cancer Patients With Shortness of Breath | NCT00003684 | Pulmonary Compl... Quality of Life Unspecified Adu... | theophylline quality-of-life... | 16 Years - 120 Years | Canadian Cancer Trials Group |